Towards Personalized Neoadjuvant Therapy for Muscle-invasive Bladder Cancer

被引：9

作者：

Li, Roger ^{[1
]}

Spiess, Philippe E. ^{[1
]}

Gilbert, Scott M. ^{[1
]}

Necchi, Andrea ^{[2
]}

机构：

[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, 12902 USF Magnolia Dr, Tampa, FL 33612 USA

[2] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, Milan, Italy

来源：

EUROPEAN UROLOGY | 2019年 / 76卷 / 01期

关键词：

CHEMOTHERAPY;

D O I：

10.1016/j.eururo.2019.02.027

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：4 / 6

页数：3

共 50 条

[11] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
Vasdev, N.
Zargar, H.
Fairey, A.
Espiritu, P.
Krabbe, L.
Mongomery, J.
Gandhi, N.
Griffin, J.
Yu, E.
Campain, N.
Xylinas, E.
Horenblas, S.
Yousef, D.
Kassouf, W.
Shariat, S.
Aning, J.
Wright, J.
Holzbeierlein, J.
Bivalacqua, T.
Morgan, T.
North, S.
Borcas, D.
Lotan, Y.
Shah, J.
Spiess, P.
Van Rhijn, B.
Daneshmand, S.
Black, P.
Thorpe, A. C.
BJU INTERNATIONAL, 2014, 113 : 25 - 25
[12] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
Zargar, Homayoun
Espiritu, Patrick N.
Fairey, Adrian S.
Mertens, Laura S.
Dinney, Colin P.
Mir, Maria C.
Krabbe, Laura-Maria
Cookson, Michael S.
Jacobsen, Niels-Erik
Gandhi, Nilay M.
Griffin, Joshua
Montgomery, Jeffrey S.
Vasdev, Nikhil
Yu, Evan Y.
Youssef, David
Xylinas, Evanguelos
Campain, Nicholas J.
Kassouf, Wassim
Dall'Era, Marc A.
Seah, Jo-An
Ercole, Cesar E.
Horenblas, Simon
Sridhar, Srikala S.
McGrath, John S.
Aning, Jonathan
Shariat, Shahrokh F.
Wright, Jonathan L.
Thorpe, Andrew C.
Morgan, Todd M.
Holzbeierlein, Jeff M.
Bivalacqua, Trinity J.
North, Scott
Barocas, Daniel A.
Lotan, Yair
Garcia, Jorge A.
Stephenson, Andrew J.
Shah, Jay B.
van Rhijn, Bas W.
Daneshmand, Siamak
Spiess, Philippe E.
Black, Peter C.
EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
[13] Neoadjuvant Gemcitabine Plus Cisplatin for Muscle-invasive Bladder Cancer
Kaneko, Gou
Kikuchi, Eiji
Matsumoto, Kazuhiro
Obata, Jun
Nakamura, So
Miyajima, Akira
Oya, Mototsugu
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (07) : 908 - 914
[14] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
Clark, Peter E.
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
[15] Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer A Model for Rational Accelerated Drug Development
Balar, Arjun V.
Milowsky, Matthew I.
UROLOGIC CLINICS OF NORTH AMERICA, 2015, 42 (02) : 217 - +
[16] Camrelizumab in combination with gemcitabine plus cisplatin as neoadjuvant therapy for muscle-invasive bladder cancer
Xing, N.
Han, S.
Jiang, J.
Xu, W.
Shi, B.
Ping, H.
Ji, Z.
Ma, Q.
Wang, H.
Chen, S.
Wang, W.
Fan, X.
Zhou, Q.
Zhang, W.
ANNALS OF ONCOLOGY, 2021, 32 : S714 - S714
[17] Using the neoadjuvant chemotherapy paradigm to develop precision therapy for muscle-invasive bladder cancer
Chedgy, Edmund C. P.
Douglas, James
Wright, Jonathan L.
Seiler, Roland
van Rhijn, Bas W. G.
Boormans, Joost
Todenhoefer, Tilman
Dinney, Colin P.
Collins, Colin C.
Van der Heijden, Michiel S.
Black, Peter C.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (10) : 469 - 476
[18] Neoadjuvant therapy with Disitamab vedotin in treating muscle-invasive bladder cancer: A case report
Huang, Haijun
Zhang, Yucong
Chen, Zhi
Zeng, Xing
Hu, Zhiquan
Yang, Chunguang
HELIYON, 2023, 9 (04)
[19] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Skyler B. Johnson
James B. Yu
Current Oncology Reports, 2018, 20
[20] Bladder Preserving Trimodality Therapy for Muscle-Invasive Bladder Cancer
Johnson, Skyler B.
Yu, James B.
CURRENT ONCOLOGY REPORTS, 2018, 20 (09)

← 1 2 3 4 5 →